NO952677L - Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater - Google Patents

Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater

Info

Publication number
NO952677L
NO952677L NO952677A NO952677A NO952677L NO 952677 L NO952677 L NO 952677L NO 952677 A NO952677 A NO 952677A NO 952677 A NO952677 A NO 952677A NO 952677 L NO952677 L NO 952677L
Authority
NO
Norway
Prior art keywords
alkyl
radical
cycloalkyl
phenyl
hydrogen
Prior art date
Application number
NO952677A
Other languages
English (en)
Other versions
NO952677D0 (no
Inventor
Gerald Guillaumet
Marie-Claude Viaud
Laurence Savelon
Panayota Pavli
Pierre Renard
Bruno Pfeiffer
Daniel-Henri Caignard
Jean-Guy Bizot-Espiard
Gerard Adam
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9408418A external-priority patent/FR2722195B1/fr
Priority claimed from FR9408419A external-priority patent/FR2722196B1/fr
Application filed by Adir filed Critical Adir
Publication of NO952677D0 publication Critical patent/NO952677D0/no
Publication of NO952677L publication Critical patent/NO952677L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

Det beskrives forbindelser med den generelle formel (I): O) R, hvor: - Rx er valgt fra hydrogen, alkyl, alkenyl, cyanoalkyl og arylalkyl, Rg W er valgt fra gruppene ¿A-R., and -(AJ^CH^N X Ra er valgt fra alkyl, cykloalkyl, cykloalkylalkyl, fenyl, fenylalkyl, naftyl og naftylalkyl, R, og R4 er valgt, hver uavhengig av den andre, fra hydrogen, alkyl, fenyl, fenylalkyl, cyclokalkyl og cykloalkylalkyl, eller de danner sammmen med nitrogenatomet som bærer dem, et hetero- cyklisk system valgt fra: ¿N ¿ CH og hvor: a representerer et heltall på fra O til 4, b representerer l eller 2, c, d, e og f representerer et heltall på fra O til 4, g representerer 4 eller 5, Z representerer O, S eller N-R,, hvor R7 representerer et hydrogenatom, eller en alkyl-, fenyl-fenylalkyl-, cyklo- alkyl-, cykloalkylalkyl-, benzhydryl-, naftyl-, pyridyl- eller pyrimidylgruppe, n representerer et heltall fra l til 4 inklusive, m representererr O eller l, O OH \\ l A er valgt fra gruppen ~ C ~ og gruppen ¿ CH ¿, Y representerer et oksygenatom eller en gruppe hvor Rs og R« begge er valgt, uavhengig av hverandre, fra hydrogen, et alkylradikal, et cykloalkylradikal, et cyloalkyl- alkylradikal, et fenylradikal og et benzylradikal, deres eventuelle geometriske og/eller optiske isomerer, i ren form eller i form av en blanding, og deres farmasøytisk akseptable addi- sjonssalter med en syre eller en base.
NO952677A 1994-07-07 1995-07-06 Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater NO952677L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408418A FR2722195B1 (fr) 1994-07-07 1994-07-07 Nouveaux derives de 1,3-dihydro-2h-pyrrolo(2,3-b) pyridin-2-ones et oxazolo(4,5-b) pyridin-2(3h)-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR9408419A FR2722196B1 (fr) 1994-07-07 1994-07-07 Nouveaux derives amines de 1,3-dihydro-2h-pyrrolo(2,3-b) pyridin-2-ones et oxazolo(4,5-b) pyridin-2 (3h)-ones, leur procede de preparation et les compositions pharmaceutique qui les contiennent

Publications (2)

Publication Number Publication Date
NO952677D0 NO952677D0 (no) 1995-07-06
NO952677L true NO952677L (no) 1996-01-08

Family

ID=26231276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952677A NO952677L (no) 1994-07-07 1995-07-06 Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater

Country Status (9)

Country Link
US (2) US5618819A (no)
EP (1) EP0691339A1 (no)
JP (1) JPH0853447A (no)
CN (1) CN1127254A (no)
AU (1) AU683167B2 (no)
CA (1) CA2153294A1 (no)
FI (1) FI953327A (no)
NO (1) NO952677L (no)
NZ (1) NZ272516A (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618819A (en) * 1994-07-07 1997-04-08 Adir Et Compagnie 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds
US6166274A (en) * 1999-12-15 2000-12-26 Atofina Chemicals, Inc. Catalyzed liquid phase fluorination of 1230za
CN101087789B (zh) * 2004-10-27 2011-01-12 詹森药业有限公司 用作黄体酮受体调节剂的吡啶并咪唑类和氮杂吲哚类化合物
DE102005007694A1 (de) * 2005-02-18 2006-09-21 Henkel Kgaa Mittel zum Färben von keratinhaltigen Fasern
MY145694A (en) * 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
MY158766A (en) * 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053713A1 (es) * 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
AU2007254179B2 (en) * 2006-05-18 2013-03-21 Pharmacyclics Llc Intracellular kinase inhibitors
CA2666143A1 (en) * 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
BRPI0719210A2 (pt) * 2006-10-12 2015-05-05 Xenon Pharmaceuticals Inc Uso de compostos espiro-oxindol como agentes terapêuticos
EP2076518A1 (en) * 2006-10-12 2009-07-08 Xenon Pharmaceuticals Inc. Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
WO2009025265A1 (ja) * 2007-08-21 2009-02-26 Shionogi & Co., Ltd. ピペラジン誘導体
CA2741024A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
CN102256983B (zh) 2008-10-17 2017-04-05 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
EP2379561B1 (en) 2008-11-25 2015-11-04 University Of Rochester Mlk inhibitors and methods of use
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
AU2010306768B2 (en) 2009-10-14 2016-08-04 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
EP2538919B1 (en) 2010-02-26 2017-07-12 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
JP6086326B2 (ja) 2010-05-24 2017-03-01 ユニヴァーシティー オブ ロチェスター 二環式ヘテロアリールキナーゼ阻害剤および使用方法
EP2707373A1 (de) 2011-05-10 2014-03-19 Bayer Intellectual Property GmbH Bicyclische (thio)carbonylamidine
BR112014004595A2 (pt) * 2011-09-01 2017-03-21 Dsm Ip Assets Bv processo para a carbonilação de alquenos opcionalmente funcionalizados
WO2014085795A1 (en) 2012-11-30 2014-06-05 University Of Rochester Mixed lineage kinase inhibitors for hiv/aids therapies
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
WO2016127068A1 (en) 2015-02-05 2016-08-11 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244507A1 (en) * 1973-06-26 1975-04-18 Inst Nat Sante Rech Med Chalcones and analogues - analgesics having low toxicity
US4038396A (en) * 1975-02-24 1977-07-26 Merck & Co., Inc. Anti-inflammatory oxazole[4,5-b]pyridines
JPS6015635B2 (ja) * 1976-05-28 1985-04-20 久光製薬株式会社 新規なオキサゾロ〔４，５−ｂ〕ピリジン誘導体
US4866074A (en) * 1987-05-08 1989-09-12 Rorer Pharmaceutical Corporation Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses
FR2650591B1 (fr) * 1989-08-07 1991-11-15 Science Organisation Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2652085A1 (fr) * 1989-09-20 1991-03-22 Science Organisation Nouveau procede de synthese de derives d'oxazolopyridines.
WO1991009598A1 (en) * 1990-01-05 1991-07-11 Pfizer Inc. Azaoxindole derivatives
FR2663929A1 (fr) * 1990-06-29 1992-01-03 Adir Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2669336B1 (fr) * 1990-11-20 1993-01-22 Adir Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5618819A (en) * 1994-07-07 1997-04-08 Adir Et Compagnie 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds

Also Published As

Publication number Publication date
FI953327A (fi) 1996-01-08
EP0691339A1 (fr) 1996-01-10
AU2482795A (en) 1996-01-18
US5618819A (en) 1997-04-08
JPH0853447A (ja) 1996-02-27
FI953327A0 (fi) 1995-07-06
NZ272516A (en) 1996-10-28
NO952677D0 (no) 1995-07-06
CN1127254A (zh) 1996-07-24
AU683167B2 (en) 1997-10-30
CA2153294A1 (fr) 1996-01-08
US5767128A (en) 1998-06-16

Similar Documents

Publication Publication Date Title
NO952677L (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
ES8302002A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
DK611686D0 (da) Pyrazolinderivater, fremgangsmaade til fremstilling deraf og deres anvendelse som middel med insekticid og akaricid virkning
ES8402273A1 (es) Un procedimiento para la preparacion de 1,4-dihidropiridinas.
ES8203888A1 (es) Procedimiento para la obtencion de dihidropiridinas susti- tuidas en la posicion 4 del hetero-anillo
NO954681L (no) Kjemiske forbindelser
MY101721A (en) 6-vinyl-furo-(3,4-c)-pyridine derivatives
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
NO934196L (no) N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for deres fremstilling
HUT36113A (en) Process for preparing dihydro-pyridibes with anti-ischaemic activity and blood pressure decreasing effect and pharmaceutical compositions containing such compounds
NO975020L (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
DK219488D0 (da) Benzo- og thieno-3,4-dihydropyridinderivater, deres fremstilling og laegemidler indeholdende forbindelserne
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
NO891381L (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
ES8801271A1 (es) Procedimiento para preparar compuestos tetraoxo
NO20010801L (no) Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
NO981000L (no) 4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelse
NO932002L (no) Nye tiosemikarbazonsyreestere
ES8504117A1 (es) Procedimiento para preparar derivados de cistamina.
DK104488A (da) Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem